Clinical Trial

Evaluate the Distribution and Dynamic Behavior of Nuclide Labeled TH-SC01 Cells in Vivo in Patients With Radiation Proctitis

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 13, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
A Phase l clinical study evaluating the distribution and dynamic behavior of Nuclide labeled TH-SC01 cells in vivo in patients with Radiation proctitis
Trial Details
NCT Number NCT06925607
Lead Sponsor Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
Conditions Radiation Proctitis
Enrollment 6 participants
Start Date 2025-04
Primary Completion 2026-03 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-04-13